Immune Repertoire Sequencing Market Analysis | CMI - PowerPoint PPT Presentation

View by Category
About This Presentation

Immune Repertoire Sequencing Market Analysis | CMI


Read here the latest updates on the Immune Repertoire Sequencing Market Analysis published by CMI team – PowerPoint PPT presentation

Number of Views:2
Date added: 5 October 2020
Slides: 13
Provided by: Shweta2707
Category: Other


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Immune Repertoire Sequencing Market Analysis | CMI

  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//
  • COVID-19 Impact Tracker

  • Immune Repertoire Sequencing Market, By Product
    Type (Assay Kits (T-Cell Receptor Kits, and
    B-Cell Receptor Kits) and Instruments), By
    Application (Cancer Immunotherapy, Biomarker
    Discovery, Autoimmune Diseases, Vaccine
    Development and Efficacy, Transplant Rejection
    and Tolerance, Infectious Diseases, and Other
    Applications), By End User (Diagnostic Labs,
    Biotechnology and Pharmaceutical Companies,
    Academic and Research Institutes, and Others),
    and By Region (North America, Latin America,
    Europe, Asia Pacific, Middle East, and Africa) -
    Size, Share, Outlook, and Opportunity Analysis,
  • The global immune repertoire sequencing market
    size was valued at US 114.3 million in 2017, and
    is expected to witness a CAGR of 5.6 over the
    forecast period (2018 2026).

Global Immune Repertoire Sequencing Market Share
() Analysis, By Product Type, 2017
Market Drivers
  • Increasing Research Development and Demand for
    Genomic and Repertoire Sequencing-based Research
    is expected to Drive Growth of the Immune
    Repertoire Sequencing Market
  • Increasing research and development and launches
    of novel products by key players are expected to
    be the major driving force for global immune
    repertoire sequencing market growth in the near
    future. For instance, in 2016, ArcherDX, Inc.
    expanded its product portfolio with the launch of
    Archer Immunoverse immune repertoire sequencing
    assays at the American Society of Hematology
    (ASH). In 2017, ArcherDX, Inc. launched Archer
    Immunoverse B Cell Receptor (BCR) assays to
    characterize the human B cell repertoire.
  • According to a study published by Cold Spring
    Harbor Laboratory, in 2017, researchers from
    Stanford University applied immune repertoire
    sequencing to identify disease-related signatures
    in the immune systems of patients with systemic
    sclerosis-related pulmonary hypertension
    (SSc-PAH), a rare chronic autoimmune disease that
    affects the connective tissue. Therefore,
    increasing research on immune repertoire
    sequencing is expected to create a favorable
    environment for immune repertoire sequencing
    market growth in the near future.

Market Restraints
  • Challenges in immune repertoire sequencing
    include distinguishing biological variations from
    the errors and the bias introduced in different
    steps. Conventional and novel bioinformatics
    techniques such as high throughput screening,
    Haystack Heuristic, and others are not up to the
    mark due to unsatisfactory scalability and
    sensitivity, and limitation in providing
    sufficient and accurate data. Moreover, the
    differences of data generation and processing in
    different laboratories along with the challenges
    in immune repertoire sequencing system are some
    key factors, which may hamper growth of the
    immune repertoire sequencing market size.

Immune Repertoire Sequencing Market - Regional
  • On the basis of region, the global immune
    repertoire sequencing market is segmented into
    North America, Latin America, Europe, Asia
    Pacific, Middle East, and Africa. North America
    is expected to hold a dominant position in the
    global immune repertoire sequencing market during
    the forecast period, owing to high presence of
    key industry players in the region (including
    Illumina Inc., Thermo Fisher Scientific, Pacific
    Biosciences, and CD Genomics). These players are
    increasingly focusing on development of novel
    technologies for immune repertoire sequencing.
    For instance, in 2017, 10x Genomics Inc., U.S.
    based company, added B-Cell and 5Unbiased
    Enrichment Kit to its chromium immune repertoire
    profiling solution or immune repertoire
  • Europe is expected to foresee a rapid growth in
    the immune repertoire sequencing market. The
    market in Europe is expected to gain momentum
    during the forecast period, owing to rise in
    funding by the government bodies to support
    international innovative projects and marketable
    innovative products, processes, and services, in
    order to cater unmet medical need. In July 2018,
    Eurostars (a joint program between EUREKA and the
    European Commission) granted US 495,000 to OSE
    Immunotherapeutic SAs project entitled
    Treatment Response Monitoring for Cancer
    Immunotherapies Using Immune Repertoire

Global Immune Repertoire Sequencing Market Value
(US Mn) Y-o-Y Growth (), 2016-2026
Immune Repertoire Sequencing Market - Competitive
  • Key players operating in the global immune
    repertoire sequencing market include Thermo
    Fisher Scientific, Inc., Illumina Inc., ArcherDX,
    Inc., Roche Holding AG, Pacific Biosciences, CD
    Genomics, Atreca, Inc., Adaptive Biotechnologies,
    Oxford Nanopore Technologies, Ltd., Qiagen N.V.,
    Agilent Technologies, Inc., and Takara Bio, Inc.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email

  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//